Maini RN - Search Results

1

Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.

Buchan G, Barrett K, Turner M, Chantry D, Maini RN, Feldmann M. Buchan G, et al. Among authors: maini rn. Clin Exp Immunol. 1988 Sep;73(3):449-55. Clin Exp Immunol. 1988. PMID: 3264773 Free PMC article.

2

Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions.

Taylor PC, Williams RO, Maini RN. Taylor PC, et al. Among authors: maini rn. Curr Dir Autoimmun. 2000;2:83-102. doi: 10.1159/000060499. Curr Dir Autoimmun. 2000. PMID: 11791460 Review. No abstract available.

3

Tumour necrosis factor as a therapeutic target in rheumatoid arthritis and other chronic inflammatory diseases: the clinical experience with infliximab (REMICADE).

Bondeson J, Maini RN. Bondeson J, et al. Among authors: maini rn. Int J Clin Pract. 2001 Apr;55(3):211-6. Int J Clin Pract. 2001. PMID: 11351775 Review.

4

Workshop summary: health outcomes and health economic issues surrounding the use of biological therapies in patients with rheumatoid arthritis.

Maini RN, Wolfe F. Maini RN, et al. Rheumatology (Oxford). 1999 Nov;38 Suppl 2:48-9. Rheumatology (Oxford). 1999. PMID: 10646493 No abstract available.

5

Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.

Maini RN, Taylor PC, Paleolog E, Charles P, Ballara S, Brennan FM, Feldmann M. Maini RN, et al. Ann Rheum Dis. 1999 Nov;58 Suppl 1(Suppl 1):I56-60. doi: 10.1136/ard.58.2008.i56. Ann Rheum Dis. 1999. PMID: 10577974 Free PMC article. Review. No abstract available.

6

The rationale for the current boom in anti-TNFalpha treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNFalpha and minimise hazards?

Feldmann M, Bondeson J, Brennan FM, Foxwell BM, Maini RN. Feldmann M, et al. Among authors: maini rn. Ann Rheum Dis. 1999 Nov;58 Suppl 1(Suppl 1):I27-31. doi: 10.1136/ard.58.2008.i27. Ann Rheum Dis. 1999. PMID: 10577970 Free PMC article. Review.

7

Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.

Charles P, Elliott MJ, Davis D, Potter A, Kalden JR, Antoni C, Breedveld FC, Smolen JS, Eberl G, deWoody K, Feldmann M, Maini RN. Charles P, et al. Among authors: maini rn. J Immunol. 1999 Aug 1;163(3):1521-8. J Immunol. 1999. PMID: 10415055 Free article. Clinical Trial.

8

Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases.

Feldman M, Taylor P, Paleolog E, Brennan FM, Maini RN. Feldman M, et al. Among authors: maini rn. Transplant Proc. 1998 Dec;30(8):4126-7. doi: 10.1016/s0041-1345(98)01365-7. Transplant Proc. 1998. PMID: 9865320 Review. No abstract available.

9

Rheumatoid arthritis. A paradigm of inflammatory disease of the musculoskeletal system.

Maini RN. Maini RN. Acta Orthop Scand Suppl. 1998 Jun;281:6-13. Acta Orthop Scand Suppl. 1998. PMID: 9771534 No abstract available.

10

Suppression of collagen-induced arthritis by continuous administration of IL-4.

Horsfall AC, Butler DM, Marinova L, Warden PJ, Williams RO, Maini RN, Feldmann M. Horsfall AC, et al. Among authors: maini rn. J Immunol. 1997 Dec 1;159(11):5687-96. J Immunol. 1997. PMID: 9548513

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results